The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Total Artificial Heart-Global Market Insights and Sales Trends 2025
Synopsis
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
The global Total Artificial Heart market size is expected to reach US$ 156.5 million by 2029, growing at a CAGR of 21.7% from 2023 to 2029. The market is mainly driven by the significant applications of Total Artificial Heart in various end use industries. The expanding demands from the Dilated Cardiomyopathy, Ischemic Cardiomyopathy and Others,, are propelling Total Artificial Heart market. SynCardia, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
Global Total Artificial Heart key players include only SynCardia, with a share about 100%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 40 percent. In terms of product, SynCardia is the largest segment, with a share about 100%. And in terms of application, the largest application is Ischemic Cardiomyopathy, followed by Dilated Cardiomyopathy, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Total Artificial Heart, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Total Artificial Heart market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Total Artificial Heart market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Total Artificial Heart sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Total Artificial Heart covered in this report include BiVACOR, SynCardia, Jarvik Heart, CARMAT and AbioMed, etc.
The global Total Artificial Heart market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
Global Total Artificial Heart market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Total Artificial Heart market, Segment by Type:
SynCardia
Others
Global Total Artificial Heart market, by Application
Dilated Cardiomyopathy
Ischemic Cardiomyopathy
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Total Artificial Heart manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Total Artificial Heart in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
The global Total Artificial Heart market size is expected to reach US$ 156.5 million by 2029, growing at a CAGR of 21.7% from 2023 to 2029. The market is mainly driven by the significant applications of Total Artificial Heart in various end use industries. The expanding demands from the Dilated Cardiomyopathy, Ischemic Cardiomyopathy and Others,, are propelling Total Artificial Heart market. SynCardia, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
Global Total Artificial Heart key players include only SynCardia, with a share about 100%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 40 percent. In terms of product, SynCardia is the largest segment, with a share about 100%. And in terms of application, the largest application is Ischemic Cardiomyopathy, followed by Dilated Cardiomyopathy, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Total Artificial Heart, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Total Artificial Heart market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Total Artificial Heart market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Total Artificial Heart sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Total Artificial Heart covered in this report include BiVACOR, SynCardia, Jarvik Heart, CARMAT and AbioMed, etc.
The global Total Artificial Heart market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
Global Total Artificial Heart market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Total Artificial Heart market, Segment by Type:
SynCardia
Others
Global Total Artificial Heart market, by Application
Dilated Cardiomyopathy
Ischemic Cardiomyopathy
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Total Artificial Heart manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Total Artificial Heart in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Total Artificial Heart Market Overview
1.1 Total Artificial Heart Product Overview
1.2 Total Artificial Heart Market Segment by Type
1.2.1 SynCardia
1.2.2 Others
1.3 Global Total Artificial Heart Market Size by Type
1.3.1 Global Total Artificial Heart Market Size Overview by Type (2018-2029)
1.3.2 Global Total Artificial Heart Historic Market Size Review by Type (2018-2023)
1.3.3 Global Total Artificial Heart Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Total Artificial Heart Sales Breakdown by Type (2018-2023)
1.4.2 Europe Total Artificial Heart Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Total Artificial Heart Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Total Artificial Heart Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Total Artificial Heart Sales Breakdown by Type (2018-2023)
2 Global Total Artificial Heart Market Competition by Company
2.1 Global Top Players by Total Artificial Heart Sales (2018-2023)
2.2 Global Top Players by Total Artificial Heart Revenue (2018-2023)
2.3 Global Top Players by Total Artificial Heart Price (2018-2023)
2.4 Global Top Manufacturers Total Artificial Heart Manufacturing Base Distribution, Sales Area, Product Type
2.5 Total Artificial Heart Market Competitive Situation and Trends
2.5.1 Total Artificial Heart Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Total Artificial Heart Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Total Artificial Heart as of 2022)
2.7 Date of Key Manufacturers Enter into Total Artificial Heart Market
2.8 Key Manufacturers Total Artificial Heart Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Total Artificial Heart Status and Outlook by Region
3.1 Global Total Artificial Heart Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Total Artificial Heart Historic Market Size by Region
3.2.1 Global Total Artificial Heart Sales in Volume by Region (2018-2023)
3.2.2 Global Total Artificial Heart Sales in Value by Region (2018-2023)
3.2.3 Global Total Artificial Heart Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Total Artificial Heart Forecasted Market Size by Region
3.3.1 Global Total Artificial Heart Sales in Volume by Region (2024-2029)
3.3.2 Global Total Artificial Heart Sales in Value by Region (2024-2029)
3.3.3 Global Total Artificial Heart Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Total Artificial Heart by Application
4.1 Total Artificial Heart Market Segment by Application
4.1.1 Dilated Cardiomyopathy
4.1.2 Ischemic Cardiomyopathy
4.1.3 Others
4.2 Global Total Artificial Heart Market Size by Application
4.2.1 Global Total Artificial Heart Market Size Overview by Application (2018-2029)
4.2.2 Global Total Artificial Heart Historic Market Size Review by Application (2018-2023)
4.2.3 Global Total Artificial Heart Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Total Artificial Heart Sales Breakdown by Application (2018-2023)
4.3.2 Europe Total Artificial Heart Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Total Artificial Heart Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Total Artificial Heart Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Total Artificial Heart Sales Breakdown by Application (2018-2023)
5 North America Total Artificial Heart by Country
5.1 North America Total Artificial Heart Historic Market Size by Country
5.1.1 North America Total Artificial Heart Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Total Artificial Heart Sales in Volume by Country (2018-2023)
5.1.3 North America Total Artificial Heart Sales in Value by Country (2018-2023)
5.2 North America Total Artificial Heart Forecasted Market Size by Country
5.2.1 North America Total Artificial Heart Sales in Volume by Country (2024-2029)
5.2.2 North America Total Artificial Heart Sales in Value by Country (2024-2029)
6 Europe Total Artificial Heart by Country
6.1 Europe Total Artificial Heart Historic Market Size by Country
6.1.1 Europe Total Artificial Heart Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Total Artificial Heart Sales in Volume by Country (2018-2023)
6.1.3 Europe Total Artificial Heart Sales in Value by Country (2018-2023)
6.2 Europe Total Artificial Heart Forecasted Market Size by Country
6.2.1 Europe Total Artificial Heart Sales in Volume by Country (2024-2029)
6.2.2 Europe Total Artificial Heart Sales in Value by Country (2024-2029)
7 Asia-Pacific Total Artificial Heart by Region
7.1 Asia-Pacific Total Artificial Heart Historic Market Size by Region
7.1.1 Asia-Pacific Total Artificial Heart Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Total Artificial Heart Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Total Artificial Heart Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Total Artificial Heart Forecasted Market Size by Region
7.2.1 Asia-Pacific Total Artificial Heart Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Total Artificial Heart Sales in Value by Region (2024-2029)
8 Latin America Total Artificial Heart by Country
8.1 Latin America Total Artificial Heart Historic Market Size by Country
8.1.1 Latin America Total Artificial Heart Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Total Artificial Heart Sales in Volume by Country (2018-2023)
8.1.3 Latin America Total Artificial Heart Sales in Value by Country (2018-2023)
8.2 Latin America Total Artificial Heart Forecasted Market Size by Country
8.2.1 Latin America Total Artificial Heart Sales in Volume by Country (2024-2029)
8.2.2 Latin America Total Artificial Heart Sales in Value by Country (2024-2029)
9 Middle East and Africa Total Artificial Heart by Country
9.1 Middle East and Africa Total Artificial Heart Historic Market Size by Country
9.1.1 Middle East and Africa Total Artificial Heart Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Total Artificial Heart Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Total Artificial Heart Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Total Artificial Heart Forecasted Market Size by Country
9.2.1 Middle East and Africa Total Artificial Heart Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Total Artificial Heart Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 BiVACOR
10.1.1 BiVACOR Company Information
10.1.2 BiVACOR Introduction and Business Overview
10.1.3 BiVACOR Total Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.1.4 BiVACOR Total Artificial Heart Products Offered
10.1.5 BiVACOR Recent Development
10.2 SynCardia
10.2.1 SynCardia Company Information
10.2.2 SynCardia Introduction and Business Overview
10.2.3 SynCardia Total Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.2.4 SynCardia Total Artificial Heart Products Offered
10.2.5 SynCardia Recent Development
10.3 Jarvik Heart
10.3.1 Jarvik Heart Company Information
10.3.2 Jarvik Heart Introduction and Business Overview
10.3.3 Jarvik Heart Total Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Jarvik Heart Total Artificial Heart Products Offered
10.3.5 Jarvik Heart Recent Development
10.4 CARMAT
10.4.1 CARMAT Company Information
10.4.2 CARMAT Introduction and Business Overview
10.4.3 CARMAT Total Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.4.4 CARMAT Total Artificial Heart Products Offered
10.4.5 CARMAT Recent Development
10.5 AbioMed
10.5.1 AbioMed Company Information
10.5.2 AbioMed Introduction and Business Overview
10.5.3 AbioMed Total Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.5.4 AbioMed Total Artificial Heart Products Offered
10.5.5 AbioMed Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Total Artificial Heart Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Total Artificial Heart Industrial Chain Analysis
11.4 Total Artificial Heart Market Dynamics
11.4.1 Total Artificial Heart Industry Trends
11.4.2 Total Artificial Heart Market Drivers
11.4.3 Total Artificial Heart Market Challenges
11.4.4 Total Artificial Heart Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Total Artificial Heart Distributors
12.3 Total Artificial Heart Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
